Login
Toggle navigation
Videos
Categories
Trending
Get to know Erica Yount of Modera Wealth Management, LLC
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tom Orecchio, CFA, CFP - Chief Executive Officer - Modera Wealth Management
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Defense Metals Interview Highlights: Rare Earth Project Updates and Future Outlook
00:10:00
Exploring Political Philosophy with Mark Blitz: Insights from Harvard and Beyond|Mark Blitz,Professor,Claremont McKenna College
00:10:00
Mass Gold Corp: Saskatchewan Gold Projects Overview
00:10:00
Bittium Q2 8.8.19 | Hannu Huttunen, CEO, Bittium OyjBITTI:HEX
00:10:00
Far Resources Advances Lithium Exploration Projects in Canada
00:10:00
developers to build in-app purchases and subscriptions|Mark Fiorentino,Partner,Index Ventures
00:00:00
Tyler A. Bahr, M.D.
00:10:00
Grid Metals' PDAC Recap: CEO Robin Dunbar on Lithium Prospects and Market Strategy
00:10:00
GAN Provides US Sports Wagering Update After CoolBet Acquisition | Seamus McGill, Chief Executive Officer at GAN
00:10:00
Zenith Minerals: Gold and Copper Exploration Updates and Future Prospects
00:10:00
Scaling New Heights: Our Journey to 250,000 Ounces of Annual Gold Production
00:10:00
Market Correction: Navigating Volatility and Diversification